Nav: Home

Cancer cells' plasticity makes them harder to stop

February 07, 2019

HOUSTON - (Feb. 7, 2019) - When metastatic cancer cells need to avoid a threat, they simply reprogram themselves. Rice University scientists are beginning to get a handle on how they survive hostile environments.

Members of Rice's Center for Theoretical Biological Physics (CTBP) and cancer metabolism researchers at Baylor College of Medicine have created a basic framework of how cancer cells -- whether in tumors or as single cells -- adapt when their attempts to metastasize are blocked by drugs or the body's immune system. Understanding the cells' strategies could someday help scientists design therapies that keep them in check.

Their model shows a direct connection between gene regulation and metabolic pathways and how cancer cells take advantage of it to adapt to hostile environments, a process known as metabolic plasticity.

In particular, the team led by physicists Herbert Levine and José Onuchic and postdoctoral fellow Dongya Jia looked at oxidative phosphorylation (OXPHOS) and glycolysis, metabolic processes that provide cells with the energy and chemical building blocks they need to proliferate.

From their model, they detailed for the first time a direct association between the activities of two protein players, AMP-activated protein kinase (AMPK) and hypoxia-inducible factor-1 (HIF-1), the master regulators of OXPHOS and glycolysis, respectively, with the activities of three major metabolic pathways: glucose oxidation, glycolysis and fatty acid oxidation.

Their theoretical model was experimentally supported by Baylor cancer mitochondrial metabolism researchers led by Dr. Benny Abraham Kaipparettu.

The new study appears in the Proceedings of the National Academy of Sciences.

"A lot of early cancer papers focus on the Warburg effect, when cancer cells primarily use glycolysis even in the presence of oxygen," Onuchic said. "This is true, but it's not like cancer cells give up on other mechanisms. The more aggressive they become, the more they are able to use any available choice to acquire energy. Our model shows how that's possible."

"Only recently have people paid attention to OXPHOS," Jia added. "But they don't really understand how cancer cells regulate these two metabolic phenotypes. We want to know how cancer cells orchestrate them. Since there is an extensive cross-talk between gene regulation and metabolic pathways, we think it's necessary to simultaneously look at these two different aspects of cancer metabolism."

The researchers said their model helped the team hone in on critical processes that traditional genome-scale metabolic models might miss. "We start with simple models where we can figure out completely what's going on, and then we add details to that scaffold without losing the basic understanding of how the system's working," Levine said.

Jia's mathematical model details connections that allow cancer cells to adopt three stable metabolic states. One is a glycolytic state, characterized by high activity of HIF-1 and high activity of the glycolytic pathway. The second is an OXPHOS state, characterized by high activity of AMPK and high activity of such OXPHOS pathways as glucose oxidation and fatty acid oxidation.

The third is a hybrid metabolic state characterized by high activity of AMPK and HIF-1 and of the glycolysis and OXPHOS pathways. The Rice model revealed the presence of both HIF-1 and AMPK can lead to the hybrid state that is difficult for current cancer therapies to address.

The researchers also found the hybrid metabolic state can be promoted by the stabilization of HIF-1 and the elevated production rate of mitochondrial reactive oxygen species (ROS) in cancer cells relative to normal cells. ROS are chemically active molecules that are important to signaling but at high levels can damage cells.

Kaipparettu's Baylor team backed up the theory using gene expression data from breast cancer patients and metastatic triple negative breast cancer experimental models. Experimental evidence showed that repressing glycolytic activity in the cells activated AMPK and enhanced OXPHOS. The reverse was also true. But a combination of inhibitors that attacked both glycolysis and OXPHOS successfully eliminated the cells' metabolic plasticity.

"We're trying to push the field of metabolic modeling towards more flexibility, allowing for the decision-making processes we see in cells," Levine said. "And here we're coupling genes to metabolism in a way that's rather novel.

"It's still a limited view of all the metabolic pathways," he said. "There are yet other possibilities that are not included in our model. We eventually need to tell a more complete story to really know what's happening."
-end-
Co-authors of the paper are former Rice postdoctoral researcher Mingyang Lu, an assistant professor at The Jackson Laboratory, Bar Harbor, Maine; postdoctoral associates Kwang Hwa Jung and Jun Hyoung Park of Baylor; and Rice alumnus Linglin Yu. Levine is an adjunct professor of bioengineering at Rice and a University Distinguished Professor at Northeastern University. Onuchic is the Harry C. and Olga K. Wiess Chair of Physics, a professor of physics and astronomy, of chemistry and of biochemistry and cell biology and co-director of the CTBP.

The research was supported by the National Science Foundation; National Cancer Institute; The Jackson Laboratory; the National Institute of General Medical Sciences; the Department of Defense; the Collaborative Faculty Research Investment Program, the Dan L. Duncan Comprehensive Cancer Center and the Charles A. Sammons Cancer Center, all at Baylor; and the Breast Cancer Research Foundation.

Jeff Falk 713-348-6775 jfalk@rice.edu

Mike Williams 713-348-6728 mikewilliams@rice.edu

Read the abstract at http://www.pnas.org/cgi/doi/10.1073/pnas.1816391116.

This news release can be found online at https://news.rice.edu/2019/02/07/cancer-cells-plasticity-makes-them-harder-to-stop/

Follow Rice News and Media Relations via Twitter @RiceUNews.

Related materials:


José Onuchic: https://chemistry.rice.edu/people/jose-onuchic

Herbert Levine: http://www.bioe.neu.edu/people/levine-herbert

Benny Abraham Kaipparettu: https://www.bcm.edu/people/view/benny-kaipparettu-ph-d/b1915357-ffed-11e2-be68-080027880ca6

Center for Theoretical Biological Physics: https://ctbp.rice.edu/

Wiess School of Natural Sciences: https://naturalsciences.rice.edu

Images for download:

https://news-network.rice.edu/news/files/2019/02/0201_CANCER-1-WEB-uwdkgi.jpg

A new model by Rice University researchers details a direct connection between gene expression and metabolism and how cancer cells take advantage of it to adapt to hostile environments, a process known as metabolic plasticity. (Credit: Illustration by Dongya Jia/Rice University)

https://news-network.rice.edu/news/files/2019/02/0201_CANCER-2-WEB-11ezu6r.jpg

Rice University researchers -- from left, Dongya Jia, Herbert Levine and José Onuchic -- detail a direct connection between gene expression and metabolism and how cancer cells take advantage of it to adapt to hostile environments. (Credit: Rice University)

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,962 undergraduates and 3,027 graduate students, Rice's undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 2 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger's Personal Finance. To read "What they're saying about Rice," go to http://tinyurl.com/RiceUniversityoverview.

Rice University

Related Cancer Cells Articles:

Cancer cells send signals boosting survival and drug resistance in other cancer cells
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Single gene encourages growth of intestinal stem cells, supporting 'niche' cells -- and cancer
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Prostate cancer cells grow with malfunction of cholesterol control in cells
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Immune therapy scientists discover distinct cells that block cancer-fighting immune cells
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
New system developed that can switch on immune cells to attack cancer cells
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Sleep hormone helps breast cancer drug kill more cancer cells
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.

Related Cancer Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".